UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma

• Published in: Pathology, research and practice Vol. 247; p. 154574
• Main Authors: Jia, Qingge, Wang, Hongjie, Xiao, Xin, Sun, Yameng, Tan, Xiao, Chai, Jia, Yang, Yanru, Yin, Zhiyong, Li, Mingyang, Wang, Ke, Liu, Jin
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 01.07.2023
• Subjects: Bone Neoplasms; Breast Neoplasms; Cancer stem cells; Carcinoma, Squamous Cell - pathology; Cell Line, Tumor; Cell Proliferation - genetics; CESC; Female; Humans; Migration; Prognosis; Sincalide - pharmacology; Sincalide - therapeutic use; Ubiquitin Thiolesterase; UCHL1; Uterine Cervical Neoplasms - pathology; UCHL1; Prognosis; Cancer stem cells; CESC; Migration
• DOI: 10.1016/j.prp.2023.154574
• ISSN: 0344-0338

The incidence and death rate of cervical cancer rank fourth among female malignant tumors worldwide. A growing number of researches are devoted to exploring more effective treatment methods and cancer stem cells (CSCs) are thought to be a potential therapeutic target in cervical cancer. In our study, we focused on the expression and function of UCHL1 in cervical squamous cell carcinoma (CESC). We detected and the expression of UCHL1 in 134 CESC patients through immunohistochemistry and further confirm UCHL1 was a prognostic factor by univariate and multivariate analysis. Then, according to TCGA database for CESC, we found that UCHL1 expression correlated with the markers associated with CSCs (CD133, ABCG2 and SOX2). Therefore, we used western blot and spheroid formation assays to future evaluate the function of UCHL1 on cancer stemness in C-33A and SiHa cell lines. At the same time, we detected the cell proliferation, migration and invasion change by CCK-8 assay, scratch assay and transwell assay, when UCHL1 was knockdown or overexpressed. Finally, xenograft models were used to examine the effect of UCHL1 in vivo. We found the expression of UCHL1 in mRNA and protein was higher in tumor than in paired normal tissue and was a prognostic factor in CESC. The UCHL1 high expression group showed a shorter survival in the overall survival. According to TCGA database, the expression of UCHL1 was correlated with CD133, ABCG2 and SOX2. The results of sphere-forming ability and CSCs related markers expression were showed UCHL1 promoted cancer stemness in CESC. Similarly, CCK-8 assay, scratch assay and transwell assay were applied to demonstrate that overexpression of UCHL1 promoted the proliferation, migration and invasion in SiHa, but when UCHL1 was knockdown in C-33A, the function of UCHL1 displayed the opposite result. Finally, knockdown UCHL1 inhibited CESC tumor propagation in xenograft models. Our results suggest that UCHL1 is a prognostic factor and correlated with cancer stemness, proliferation, migration and invasion of CESC, which may provide a novel therapeutic strategy for CESC treatment.